Fairness opinions › Acquirers
Thomas H. Lee Partners: healthcare acquisitions with fairness opinions
2 public-company targets, 2010-2024, $3.7B combined enterprise value. The multiples Thomas H. Lee Partners paid and the banker analyses behind each target board's recommendation.
Deals
2
Median EV / EBITDA paid
8.3x
Median EV / revenue paid
1.66x
| Announced | Target | Acquirer | Segment | EV | EV/EBITDA | EV/Rev | DCF rate | Fairness opinion |
|---|---|---|---|---|---|---|---|---|
| 2024-02-26 | Agiliti | Thomas H. Lee Partners | Distribution and Equipment Services | $2.5B | 9.4x | 2.13x | 10.0%–11.5% | Centerview Partners |
| 2010-05-06 | inVentiv Health | Thomas H. Lee Partners | Pharmaceutical Services | $1.2B | 7.3x | 1.18x | 9.5%–10.5% | Goldman Sachs |